Market & Industry Briefs, November 2012
Brief summaries of recent medtech market and industry developments. This month we cover China’s switch to a centralized billing system, St. Jude Medical’s RESPECT PFO closure trial, FDA’s approval of HeartWare’s LVAD, and end-of-the-year medtech M&A.
You may also be interested in...
CMS Issues List Of Potential National Coverage Determination Topics
Most of the 33 items or services in the list have implications for manufacturers of medical devices, combination products or diagnostics.
Medicare Panel Laments Holes In Ventricular Assist Device Evidence Base
CMS does not currently have a national coverage determination process open on ventricular assist devices for heart failure, though the agency may open a new one, an agency official said.
Boston Scientific Enters Renal Denervation Market Via Vessix Acquisition
Deal gives Boston Scientific access to the V2 radiofrequency energy-based renal denervation catheter system for drug-resistant hypertension.